The FDA's Adverse Event Reporting System (FAERS) allows healthcare providers and patients to report suspected adverse events, contributing to ongoing safety monitoring
The mechanisms of these medications conflict fundamentally with eating disorder recovery principles
Louisans reported hearing in the last week that Compounded GLP-1 drugs for weight loss and diabetes are unapproved, raising concerns. St
Prediabetes can run in families, and sometimes you cant outrun it, said Wood
Studies have shown that hunger increases and fullness decreases during menopauseeven when intake hasnt yet changed
Managing Ozempic tongue Experts, including Tricia Quartey, D.M.D., a spokesperson for the ADA, acknowledged that one reported adverse effect noted by patients using glucagon-like peptide-1 receptor agonists is known as Ozempic tongue